ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,204 | -36.2% | 1,957 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $9,726 | +0.6% | 1,957 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $9,668 | -21.5% | 1,957 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $12,310 | -61.5% | 1,957 | -34.3% | 0.01% | -65.4% |
| Q3 2022 | $32,000 | -5.9% | 2,977 | 0.0% | 0.03% | +4.0% |
| Q2 2022 | $34,000 | +25.9% | 2,977 | 0.0% | 0.02% | +66.7% |
| Q1 2022 | $27,000 | -34.1% | 2,977 | +7.5% | 0.02% | -31.8% |
| Q4 2021 | $41,000 | -46.1% | 2,769 | -6.8% | 0.02% | -51.1% |
| Q3 2021 | $76,000 | -17.4% | 2,972 | -16.0% | 0.04% | -11.8% |
| Q2 2021 | $92,000 | -39.5% | 3,537 | -17.6% | 0.05% | -45.7% |
| Q1 2021 | $152,000 | – | 4,293 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |